V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20161972 | 20062629 | 1.78 | 89 | Adjuvant (A) | 2019-03-11 | 2019-04-08 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101453974 |
| 20161973 | 20062630 | 1.61 | 56 | Palliative (P) | 2019-03-25 | 2019-04-10 | ECX | N | N | ECX | 101586880 |
| 20161977 | 20062631 | 1.57 | 82 | Adjuvant (A) | 2017-10-20 | 2017-10-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100650615 |
| 20161979 | 20062632 | 1.59 | 107.35 | Neo-adjuvant (N) | 2017-05-29 | 2017-06-10 | ECX | 02 | null | ECX | 100608808 |
| 20161980 | 20062633 | 1.78 | 73.9 | Palliative (P) | 2018-08-26 | 2018-08-28 | ECX | 02 | N | ECX | 101822268 |
| 20161988 | 20062634 | 1.5 | 71.2 | Palliative (P) | 2018-09-30 | 2018-09-30 | ECX | 02 | N | ECX | 100248371 |
| 20161990 | 20062635 | 1.69 | 71.35 | Adjuvant (A) | 2016-10-23 | 2016-10-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100300256 |
| 20161994 | 20062636 | 1.78 | 70 | Palliative (P) | 2018-10-19 | 2018-10-27 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101352912 |
| 20162001 | 20062637 | 1.79 | 95.5 | Neo-adjuvant (N) | 2018-03-01 | 2018-03-01 | ECX | N | N | ECX | 100897109 |
| 20162002 | 20062638 | 1.5 | 60.6 | Palliative (P) | 2018-03-02 | 2018-03-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100544904 |
| 20162004 | 20062639 | 1.6 | 90.2 | Adjuvant (A) | 2017-07-09 | 2017-07-13 | ECX | 02 | N | ECX | 101746224 |
| 20162007 | 20062640 | 1.75 | 50.4 | Palliative (P) | 2016-07-21 | 2016-08-12 | CAPECITABINE + GEMCITABINE | 2 | null | CAPECITABINE + GEMCITABINE | 100158300 |
| 20162012 | 20062641 | 1.6 | 78.2 | Palliative (P) | 2019-09-09 | 2019-09-09 | CAPECITABINE + GEMCITABINE | null | N | CAPECITABINE + GEMCITABINE | 101333707 |
| 20162014 | 20062642 | 1.78 | 61 | Neo-adjuvant (N) | 2018-04-13 | 2018-04-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100905402 |
| 20162015 | 20062643 | 1.62 | 75 | null | 2019-11-30 | 2019-12-29 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101717333 |
| 20162017 | 20062644 | 1.75 | 91 | Neo-adjuvant (N) | 2017-12-20 | 2018-01-07 | ECX | N | N | ECX | 101516136 |
| 20162018 | 20062645 | 1.71 | 90 | Adjuvant (A) | 2017-01-23 | 2017-02-21 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100365457 |
| 20162019 | 20062646 | 1.58 | 82.2 | Neo-adjuvant (N) | 2017-09-04 | 2017-09-14 | ECX | 02 | N | ECX | 101565489 |
| 20162032 | 20062647 | 1.76 | 61.2 | Neo-adjuvant (N) | 2019-04-13 | 2019-04-21 | ECX | 02 | N | ECX | 100666310 |
| 20162033 | 20062648 | 1.79 | 95 | Neo-adjuvant (N) | 2017-10-16 | 2017-10-16 | ECX | 2 | N | ECX | 100232718 |
| 20162036 | 20062649 | 1.57 | 70 | Adjuvant (A) | 2019-05-06 | 2019-05-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100875485 |
| 20162037 | 20062650 | 1.65 | 74.5 | Neo-adjuvant (N) | 2018-11-15 | 2018-11-20 | ECX | 02 | N | ECX | 100944556 |
| 20162049 | 20062651 | 1.67 | 67 | Palliative (P) | 2019-04-16 | 2019-04-30 | ECX | 02 | N | CAPECITABINE + GEMCITABINE | 100103044 |
| 20162052 | 20062652 | 1.71 | 82.55 | null | 2016-03-13 | 2016-04-02 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101224518 |
| 20162053 | 20062653 | null | 72.4 | Neo-adjuvant (N) | 2016-10-21 | 2016-11-04 | ECX | 2 | N | ECX | 100969995 |
| 20162064 | 20062654 | 1.58 | 47 | null | 2016-08-05 | 2016-08-12 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100132711 |
| 20162066 | 20062655 | 1.55 | 93.4 | Adjuvant (A) | 2019-11-24 | 2019-12-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101781871 |
| 20162067 | 20062656 | 1.62 | 79.9 | null | 2020-04-09 | 2020-04-12 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100960849 |
| 20162070 | 20062657 | 1.77 | 60.8 | Neo-adjuvant (N) | 2016-05-18 | 2016-05-19 | ECX | 02 | Y | ECX | 100092006 |
| 20162077 | 20062658 | 1.74 | 54.9 | Neo-adjuvant (N) | 2019-09-24 | 2019-10-05 | ECX | N | N | ECX | 100031148 |
| 20162081 | 20062659 | 1.5 | 60.5 | Neo-adjuvant (N) | 2018-08-11 | 2018-08-11 | ECX | 2 | N | ECX | 100283824 |
| 20162084 | 20062660 | null | null | Neo-adjuvant (N) | 2016-05-20 | 2016-06-08 | ECX | N | null | ECX | 100116413 |
| 20162086 | 20062661 | 1.7 | 71.6 | null | 2018-12-29 | 2019-01-01 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100018375 |
| 20162092 | 20062662 | 1.57 | 54.4 | Adjuvant (A) | 2019-08-02 | 2019-08-17 | ECX | 02 | null | ECX | 100646124 |
| 20162093 | 20062663 | 1.6 | 46.3 | Adjuvant (A) | null | 2018-03-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101846532 |
| 20162099 | 20062664 | 1.71 | 84 | null | 2017-06-16 | 2017-06-23 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100701983 |
| 20162101 | 20062665 | 1.43 | 56 | Curative (C) | 2017-03-08 | 2017-03-21 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100710365 |
| 20162102 | 20062666 | 1.46 | 68.2 | Adjuvant (A) | 2016-07-09 | 2016-07-31 | ECX | 2 | N | ECX | 100677221 |
| 20162104 | 20062667 | 1.67 | 61.2 | Palliative (P) | 2017-01-01 | 2017-01-13 | ECX | 02 | N | ECX | 100218157 |
| 20162108 | 20062668 | 1.6 | 46.3 | Adjuvant (A) | 2019-07-19 | 2019-07-30 | ECX | 02 | N | CAPECITABINE + GEMCITABINE | 101008467 |
| 20162110 | 20062669 | 1.66 | 60 | Palliative (P) | 2017-08-16 | 2017-08-19 | ECX | N | null | ECX | 101513652 |
| 20162111 | 20062670 | 1.77 | 71 | Curative (C) | 2017-02-06 | 2017-02-18 | ECX | N | N | ECX | 100710280 |
| 20162117 | 20062671 | 1.74 | 59.75 | Neo-adjuvant (N) | 2019-06-07 | 2019-06-12 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101582163 |
| 20162120 | 20062672 | 1.7 | 58 | Palliative (P) | 2020-01-06 | 2020-01-11 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100452877 |
| 20162125 | 20062673 | 1.52 | 87.9 | Adjuvant (A) | 2016-04-02 | 2016-04-22 | ECX | N | null | ECX | 101687182 |
| 20162127 | 20062674 | 1.82 | 61 | Neo-adjuvant (N) | 2018-08-20 | 2018-08-26 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100617201 |
| 20162130 | 20062675 | 1.52 | 63.2 | Palliative (P) | 2020-07-16 | 2020-08-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100966012 |
| 20162137 | 20062676 | 1.74 | 74 | Palliative (P) | 2018-11-03 | 2018-11-15 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100499950 |
| 20162138 | 20062677 | 1.57 | 58.4 | Palliative (P) | 2018-02-24 | 2018-02-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101533777 |
| 20162141 | 20062678 | null | null | Neo-adjuvant (N) | 2017-09-16 | 2017-09-19 | ECX | N | null | ECX | 101871227 |